Literature DB >> 31745474

Multiple System Atrophy With Predominant Striatonigral Degeneration and TAR DNA-Binding Protein of 43 kDa Pathology: An Unusual Variant of Multiple System Atrophy.

Lynda Nwabuobi1, Darya Tomishon1, Neil A Shneider1, Stanley Fahn1, Jean Paul Vonsattel2, Etty Cortes2.   

Abstract

BACKGROUND: The pathological hallmark in MSA is oligodendrocytic glial cytoplasmic inclusions (GCIs) containing α-synuclein, in addition to neuronal loss and astrogliosis especially involving the striatonigral and olivopontocerebellar systems. Rarely, TAR DNA-binding protein of 43 kDa (TDP-43), a component of ubiquitinated inclusions observed mainly in amyotrophic lateral sclerosis and frontotemporal lobar degeneration has been demonstrated in cases of MSA and, more recently, was shown to colocalize with α-synuclein pathology in GCIs in 2 patients.
METHODS: A 66-year-old woman presented with a syndrome characterized by spasticity, dysautonomia, bulbar dysfunction, and parkinsonism. Symptoms progressed until her death at age 74. Neuropathological evaluation was performed at the New York Brain Bank at Columbia University.
RESULTS: On gross examination, there was striking severe volume loss of the left striatum compared to mild involvement of the right striatum. Microscopically, neuronal loss and gliosis of the putamen and globus pallidus were severe on the left side, in contrast to mild involvement on the right side. Immunohistochemistry for α-synuclein revealed widespread GCIs. The sections subjected to TDP-43 antibodies showed a few GCIs with definite nucleocytoplasmic translocation of the labeling within the lenticular nucleus and within the paracentral cortex.
CONCLUSIONS: This report adds to the evidence that TDP-43 and α-synuclein colocalize in GCIs. Whether this coexistence contributes to the pathogenesis of a subset of MSA patients or is an age-related process is not known. More cases with these peculiar pathological hallmarks might help determine whether TDP-43 contributes to neurodegeneration in a subset of patients with MSA.
© 2019 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  TDP‐43; multiple system atrophy; parkinsonism; α‐synuclein

Year:  2019        PMID: 31745474      PMCID: PMC6856463          DOI: 10.1002/mdc3.12823

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  16 in total

Review 1.  Primary lateral sclerosis.

Authors:  Mike A Singer; Jeffrey M Statland; Gil I Wolfe; Richard J Barohn
Journal:  Muscle Nerve       Date:  2007-03       Impact factor: 3.217

2.  TDP-43 pathology in multiple system atrophy: colocalization of TDP-43 and α-synuclein in glial cytoplasmic inclusions.

Authors:  S Koga; W-L Lin; R L Walton; O A Ross; D W Dickson
Journal:  Neuropathol Appl Neurobiol       Date:  2018-05-09       Impact factor: 8.090

3.  Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness.

Authors:  Felix Geser; John L Robinson; Joseph A Malunda; Sharon X Xie; Chris M Clark; Linda K Kwong; Paul J Moberg; Erika M Moore; Vivianna M Van Deerlin; Virginia M-Y Lee; Steven E Arnold; John Q Trojanowski
Journal:  Arch Neurol       Date:  2010-10

4.  Multiple system atrophy: a review of 203 pathologically proven cases.

Authors:  G K Wenning; F Tison; Y Ben Shlomo; S E Daniel; N P Quinn
Journal:  Mov Disord       Date:  1997-03       Impact factor: 10.338

5.  TDP-43 pathology occurs infrequently in multiple system atrophy.

Authors:  F Geser; J A Malunda; H I Hurtig; J E Duda; G K Wenning; S Gilman; P A Low; V M-Y Lee; J Q Trojanowski
Journal:  Neuropathol Appl Neurobiol       Date:  2011-06       Impact factor: 8.090

6.  The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology.

Authors:  M I Papp; P L Lantos
Journal:  Brain       Date:  1994-04       Impact factor: 13.501

Review 7.  Neuropathologic changes of multiple system atrophy and diffuse Lewy body disease.

Authors:  Etty Paola Cortes Ramirez; Jean Paul G Vonsattel
Journal:  Semin Neurol       Date:  2014-06-25       Impact factor: 3.420

Review 8.  Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases.

Authors:  Felix Geser; Maria Martinez-Lage; Linda K Kwong; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Neurol       Date:  2009-03-07       Impact factor: 4.849

9.  Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD.

Authors:  Naomi Kouri; Kenichi Oshima; Makio Takahashi; Melissa E Murray; Zeshan Ahmed; Joseph E Parisi; Shu-Hui C Yen; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2013-01-31       Impact factor: 17.088

10.  Incidence and extent of TDP-43 accumulation in aging human brain.

Authors:  Akiko Uchino; Masaki Takao; Hiroyuki Hatsuta; Hiroyuki Sumikura; Yuta Nakano; Akane Nogami; Yuko Saito; Tomio Arai; Kazutoshi Nishiyama; Shigeo Murayama
Journal:  Acta Neuropathol Commun       Date:  2015-06-20       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.